CN109402002A - 一种加氏乳杆菌及其在制备预防早产药物中的应用 - Google Patents
一种加氏乳杆菌及其在制备预防早产药物中的应用 Download PDFInfo
- Publication number
- CN109402002A CN109402002A CN201811292997.7A CN201811292997A CN109402002A CN 109402002 A CN109402002 A CN 109402002A CN 201811292997 A CN201811292997 A CN 201811292997A CN 109402002 A CN109402002 A CN 109402002A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus gasseri
- premature labor
- drug
- lactobacillus
- gasseri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186606 Lactobacillus gasseri Species 0.000 title claims abstract description 75
- 208000006399 Premature Obstetric Labor Diseases 0.000 title claims abstract description 42
- 206010036600 Premature labour Diseases 0.000 title claims abstract description 40
- 208000026440 premature labor Diseases 0.000 title claims abstract description 40
- 239000003814 drug Substances 0.000 title claims abstract description 22
- 229940079593 drug Drugs 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 230000002265 prevention Effects 0.000 title abstract description 7
- 230000001580 bacterial effect Effects 0.000 claims abstract description 26
- 210000001215 vagina Anatomy 0.000 claims abstract description 20
- 238000004321 preservation Methods 0.000 claims abstract description 12
- 206010061218 Inflammation Diseases 0.000 claims abstract description 4
- 208000002787 Pregnancy Complications Diseases 0.000 claims abstract description 4
- 230000004054 inflammatory process Effects 0.000 claims abstract description 4
- 241000894006 Bacteria Species 0.000 claims description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
- 201000010099 disease Diseases 0.000 claims description 16
- 241000588724 Escherichia coli Species 0.000 claims description 15
- 244000052616 bacterial pathogen Species 0.000 claims description 11
- 241000191967 Staphylococcus aureus Species 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 6
- 241000207202 Gardnerella Species 0.000 claims description 3
- 241000194017 Streptococcus Species 0.000 claims description 3
- 210000000981 epithelium Anatomy 0.000 claims description 3
- 241000588653 Neisseria Species 0.000 claims description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 abstract description 8
- 210000002919 epithelial cell Anatomy 0.000 abstract description 7
- 230000035935 pregnancy Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 4
- 241000589516 Pseudomonas Species 0.000 abstract 1
- 230000001846 repelling effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 40
- 241000186660 Lactobacillus Species 0.000 description 21
- 229940039696 lactobacillus Drugs 0.000 description 21
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 239000002609 medium Substances 0.000 description 18
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- 235000015097 nutrients Nutrition 0.000 description 15
- 239000012530 fluid Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 241000207201 Gardnerella vaginalis Species 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 238000011160 research Methods 0.000 description 7
- 230000008485 antagonism Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 201000008100 Vaginitis Diseases 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 4
- 241001478240 Coccus Species 0.000 description 4
- 241000186783 Lactobacillus vaginalis Species 0.000 description 4
- 208000005107 Premature Birth Diseases 0.000 description 4
- 206010046914 Vaginal infection Diseases 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000902 placebo Substances 0.000 description 4
- 229940068196 placebo Drugs 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 208000003107 Premature Rupture Fetal Membranes Diseases 0.000 description 2
- 206010036595 Premature delivery Diseases 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 208000037009 Vaginitis bacterial Diseases 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 241001148470 aerobic bacillus Species 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021718 Induced labour Diseases 0.000 description 1
- 241000218492 Lactobacillus crispatus Species 0.000 description 1
- 101001076687 Lactobacillus gasseri Inulosucrase Proteins 0.000 description 1
- 241001561398 Lactobacillus jensenii Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000204048 Mycoplasma hominis Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 206010036603 Premature rupture of membranes Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 1
- 241000202898 Ureaplasma Species 0.000 description 1
- 208000032159 Vaginal inflammation Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000004956 cell adhesive effect Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000003785 decidua Anatomy 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 239000006153 eosin methylene blue Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 208000008881 preterm premature rupture of the membranes Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Genetics & Genomics (AREA)
- Gynecology & Obstetrics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pregnancy & Childbirth (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Tropical Medicine & Parasitology (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811292997.7A CN109402002B (zh) | 2018-11-01 | 2018-11-01 | 一种加氏乳杆菌及其在制备预防早产药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811292997.7A CN109402002B (zh) | 2018-11-01 | 2018-11-01 | 一种加氏乳杆菌及其在制备预防早产药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109402002A true CN109402002A (zh) | 2019-03-01 |
CN109402002B CN109402002B (zh) | 2021-10-08 |
Family
ID=65470800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811292997.7A Active CN109402002B (zh) | 2018-11-01 | 2018-11-01 | 一种加氏乳杆菌及其在制备预防早产药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109402002B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111518724A (zh) * | 2020-01-19 | 2020-08-11 | 河北医科大学 | 格氏乳杆菌hmv18及其外泌蛋白和应用 |
RU2742110C1 (ru) * | 2020-03-19 | 2021-02-02 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПбГПМУ Минздрава России) | Способ диагностики состояния микрофлоры влагалища и кишечника у женщин с осложненной беременностью |
CN112458006A (zh) * | 2020-11-10 | 2021-03-09 | 深圳华大生命科学研究院 | 用于预防和/或治疗生殖道菌群紊乱相关疾病的格氏乳杆菌 |
CN113797158A (zh) * | 2021-10-12 | 2021-12-17 | 南京工业大学 | 一种含活性加氏乳杆菌的妇科原位温敏凝胶制剂及其制备和应用 |
CN114214256A (zh) * | 2022-01-12 | 2022-03-22 | 哈尔滨美华生物技术股份有限公司 | 一株用于防治泌尿生殖感染的格氏乳杆菌及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103911306A (zh) * | 2013-01-05 | 2014-07-09 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
CN103911309A (zh) * | 2013-01-05 | 2014-07-09 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
CN104178437A (zh) * | 2013-11-08 | 2014-12-03 | 苏州欧赛微科生物医药科技有限公司 | 一种卷曲乳杆菌及其在妇科疾病中的应用 |
CN108004187A (zh) * | 2018-01-11 | 2018-05-08 | 广东龙创基药业有限公司 | 一种格氏乳杆菌及其用于制备阴道抑菌药物的应用 |
-
2018
- 2018-11-01 CN CN201811292997.7A patent/CN109402002B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103911306A (zh) * | 2013-01-05 | 2014-07-09 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
CN103911309A (zh) * | 2013-01-05 | 2014-07-09 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
CN104178437A (zh) * | 2013-11-08 | 2014-12-03 | 苏州欧赛微科生物医药科技有限公司 | 一种卷曲乳杆菌及其在妇科疾病中的应用 |
CN108004187A (zh) * | 2018-01-11 | 2018-05-08 | 广东龙创基药业有限公司 | 一种格氏乳杆菌及其用于制备阴道抑菌药物的应用 |
Non-Patent Citations (3)
Title |
---|
桑佳特等: "健康女性阴道乳杆菌抑菌功能的初步研究", 《现代妇产科进展》 * |
武香玉等: "健康妇女阴道乳杆菌的分离鉴定", 《药学研究》 * |
赵慧等: "女性阴道中产细菌素的乳杆菌筛选与鉴定", 《中国微生态学杂志》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111518724A (zh) * | 2020-01-19 | 2020-08-11 | 河北医科大学 | 格氏乳杆菌hmv18及其外泌蛋白和应用 |
CN111518724B (zh) * | 2020-01-19 | 2021-04-06 | 河北医科大学 | 格氏乳杆菌hmv18及其外泌蛋白和应用 |
RU2742110C1 (ru) * | 2020-03-19 | 2021-02-02 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПбГПМУ Минздрава России) | Способ диагностики состояния микрофлоры влагалища и кишечника у женщин с осложненной беременностью |
CN112458006A (zh) * | 2020-11-10 | 2021-03-09 | 深圳华大生命科学研究院 | 用于预防和/或治疗生殖道菌群紊乱相关疾病的格氏乳杆菌 |
CN113797158A (zh) * | 2021-10-12 | 2021-12-17 | 南京工业大学 | 一种含活性加氏乳杆菌的妇科原位温敏凝胶制剂及其制备和应用 |
CN113797158B (zh) * | 2021-10-12 | 2023-08-04 | 南京工业大学 | 一种含活性加氏乳杆菌的妇科原位温敏凝胶制剂及其制备和应用 |
CN114214256A (zh) * | 2022-01-12 | 2022-03-22 | 哈尔滨美华生物技术股份有限公司 | 一株用于防治泌尿生殖感染的格氏乳杆菌及其应用 |
CN114214256B (zh) * | 2022-01-12 | 2022-06-28 | 哈尔滨美华生物技术股份有限公司 | 一株用于防治泌尿生殖感染的格氏乳杆菌及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109402002B (zh) | 2021-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022100633A1 (zh) | 用于预防和/或治疗生殖道菌群紊乱相关疾病的格氏乳杆菌 | |
CN109402002A (zh) | 一种加氏乳杆菌及其在制备预防早产药物中的应用 | |
TWI652343B (zh) | 一種捲曲乳桿菌(lactobacillus crispatus)及其應用 | |
JP7354274B2 (ja) | 複合ラクトバチルス組成物およびその女性の膣の健康における用途 | |
WO2022100631A1 (zh) | 用于预防和/或治疗生殖道菌群紊乱相关疾病的卷曲乳杆菌 | |
Levison et al. | Quantitative microflora of the vagina | |
US6093394A (en) | Vaginal lactobacillus medicant | |
ES2305313T3 (es) | Bacterias que producen acido lactico para el uso como organismos probioticos en la vagina humana. | |
TWI627276B (zh) | 新穎之卷曲乳酸桿菌(lactobacillus crispatus)菌株 | |
CN110777087B (zh) | 一种约氏乳杆菌及其应用 | |
CN103409334B (zh) | 抑制阴道炎病原菌之乳酸杆菌及其用途 | |
CN107815432B (zh) | 一种人用灭活乳酸菌制剂及其用途 | |
CN1888051A (zh) | 一株植物乳杆菌及其应用 | |
WO2022100632A1 (zh) | 用于预防和/或治疗生殖道菌群紊乱和/或骨质流失引起的疾病的鼠李糖乳杆菌 | |
TW201212935A (en) | Antimicrobial agent | |
CN117143783B (zh) | 一种唾液联合乳杆菌vb330及其应用 | |
CN101543514A (zh) | 预防或治疗阴道炎的复合乳酸菌洁阴护理液及工艺 | |
TW201316996A (zh) | 抑制陰道炎病原菌之乳酸桿菌及其用途 | |
CN109394796A (zh) | 卷曲乳杆菌制剂及其应用 | |
EP4274590A1 (en) | Strains, compositions and methods of use | |
CN114164157A (zh) | 用以抑制发炎缓解牙龈肿痛改善口腔菌群平衡的唾液乳杆菌菌株zk-88 | |
ES2891536T3 (es) | Cepa Bifidobacterium animalis AMT30 y composición que contiene la cepa de Bifidobacterium animalis AMT30 | |
WO2020165919A1 (en) | A composition for competitive inhibition of pathogens and restoration of microbial ecological balance | |
Babenko et al. | Prophylactic effect of lactobacilli and bifidobacteria probiotic strains on experimental bacterial vaginitis | |
CN110538201A (zh) | 一种乳杆菌组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zeng Jimeng Inventor after: Huang Baoqi Inventor after: Song Ping Inventor after: Zhao Ye Inventor after: Hu Peng Inventor after: Chen Shuai Inventor before: Zeng Jimeng Inventor before: Song Ping Inventor before: Zhao Ye Inventor before: Hu Peng Inventor before: Chen Shuai Inventor before: Huang Baoqi |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zeng Jimeng Inventor after: Huang Baoqi Inventor after: Song Ping Inventor after: Zhao Ye Inventor after: Hu Peng Inventor after: Chen Shuai Inventor before: Zeng Jimeng Inventor before: Huang Baoqi Inventor before: Song Ping Inventor before: Zhao Ye Inventor before: Hu Peng Inventor before: Chen Shuai |
|
CB03 | Change of inventor or designer information |